Target intelligence / Profile preview

Wntless Wnt transport mediator (WLS) (WLS)

Target
WLS
Molecular classification
Transmembrane protein, Wnt transport mediator, G protein-coupled receptor (orphan)
01

Overview

Wntless Wnt transport mediator (WLS), also known as GPR177, is a highly conserved multipass transmembrane protein essential for the secretion of all Wnt signaling ligands. It functions as a dedicated cargo receptor that escorts lipidated Wnt proteins from the Golgi apparatus to the cell surface. In the context of pancreatic development, WLS-mediated Wnt secretion is critical for the expansion and compartmentalization of multipotent pancreatic progenitor cells. Dysregulation of WLS is frequently observed in various malignancies, particularly pancreatic ductal adenocarcinoma, where its overexpression drives aberrant canonical Wnt pathway activation and promotes tumor progression. Consequently, WLS is considered a significant therapeutic target, with research focusing on small molecule inhibitors and antibodies to block Wnt secretion and suppress oncogenic signaling. Its role in maintaining adult tissue homeostasis, however, poses challenges for therapeutic window and safety.

Other names
GPR177WntlessEviEvenness interruptedG protein-coupled receptor 177C1orf139MRP
02

Mechanism of action

Wntless (WLS/GPR177) acts as a specialized cargo receptor that binds to lipid-modified Wnt proteins in the endoplasmic reticulum and Golgi apparatus, transporting them to the plasma membrane for secretion. By facilitating the release of Wnt ligands, it enables the activation of the canonical Wnt/beta-catenin signaling pathway in receiving cells, such as pancreatic progenitor cells, which is essential for their expansion and subsequent differentiation during organogenesis.

03

Biological functions

Wnt protein secretionSignal transductionCell proliferationCell differentiationPancreatic progenitor expansion
04

Disease associations

CancerPancreatic ductal adenocarcinomaColorectal cancerDevelopmental disorders
05

Safety considerations

Gastrointestinal toxicityBone density lossImpaired tissue regenerationDevelopmental toxicity
06

Interacting drugs

LGK974 (indirectly affects Wnt pathway)

1 more in the full profile.

07

Biomarkers

WLS expression levelsNuclear beta-catenin localizationAXIN2 expression

Beyond the preview

Go deeper on Wntless Wnt transport mediator (WLS) (WLS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wntless Wnt transport mediator (WLS) (WLS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call